PORTAGE BIOTECH INC.

Analyst Reco. Portage Biotech Inc.

Equities

PRTG

VGG7185A1286

Market Closed - Nasdaq Other stock markets 21:30:00 17/06/2024 BST			5-day change	1st Jan Change
0.24 ^USD	-4.00%		-15.19%	-86.81%

06-03	Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	MT
06-03	Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades Portage Biotech to Neutral From Buy	01-08	MT
HC Wainwright Cuts Price Target on Portage Biotech to $9 From $21, Maintains Buy Rating	02/08/23	MT
Cantor Fitzgerald Adjusts Price Target on Portage Biotech to $11 From $16, Maintains Overweight Rating	01/08/23	MT
HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating	01/12/22	MT
Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating	30/11/22	MT
HC Wainwright Adjusts Price Target on Portage Biotech to $22 From $32, Reiterates Buy Rating	20/09/22	MT
Cantor Fitzgerald Adjusts Portage Biotech Price Target to $26 From $35, Maintains Overweight Rating	02/08/22	MT
HC Wainwright Initiates Portage Biotech at Buy with $32 Price Target	07/03/22	MT
PORTAGE BIOTECH : Oppenheimer Initiates Coverage on Portage Biotech With Outperform Rating, $30 Price Target	21/09/21	MT
PORTAGE BIOTECH : B. Riley Starts Portage Biotech at Buy with $40 PT, Notes 'Significant' Upside Potential in Solid Tumor Markets	02/09/21	MT
PORTAGE BIOTECH : Cantor Fitzgerald Starts Portage Biotech at Overweight With $35 Price Target	19/08/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW